Prognostic Relevance of Cardiopulmonary Exercise Testing for Patients with Chronic Thromboembolic Pulmonary Hypertension.

all-cause mortality balloon pulmonary angioplasty cardiopulmonary exercise testing chronic thromboembolic pulmonary disease chronic thromboembolic pulmonary hypertension comorbidities lung function prognosis pulmonary endarterectomy therapy

Journal

Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414

Informations de publication

Date de publication:
01 Oct 2022
Historique:
received: 26 08 2022
revised: 25 09 2022
accepted: 28 09 2022
entrez: 26 10 2022
pubmed: 27 10 2022
medline: 27 10 2022
Statut: epublish

Résumé

Background: Following acute pulmonary embolism (PE), a relevant number of patients experience decreased exercise capacity which can be associated with disturbed pulmonary perfusion. Cardiopulmonary exercise testing (CPET) shows several patterns typical for disturbed pulmonary perfusion. Research question: We aimed to examine whether CPET can also provide prognostic information in chronic thromboembolic pulmonary hypertension (CTEPH). Study Design and Methods: We performed a multicenter retrospective chart review in Germany between 2002 and 2020. Patients with CTEPH were included if they had ≥6 months of follow-up and complete CPET and hemodynamic data. Symptom-limited CPET was performed using a cycle ergometer (ramp or Jones protocol). The association of anthropometric data, comorbidities, symptoms, lung function, and echocardiographic, hemodynamic, and CPET parameters with survival was examined. Mortality prediction models were calculated by Cox regression with backward selection. Results: 345 patients (1532 person-years) were included; 138 underwent surgical treatment (pulmonary endarterectomy or balloon pulmonary angioplasty) and 207 received only non-surgical treatment. During follow-up (median 3.5 years), 78 patients died. The death rate per 1000 person-years was 24.9 and 74.2 in the surgical and non-surgical groups, respectively (p < 0.001). In age- and sex-adjusted Cox regression analyses, CPET parameters including peak oxygen uptake (VO2peak, reflecting cardiopulmonary exercise capacity) were prognostic in the non-surgical group but not in the surgical group. In mortality prediction models, age, sex, VO2peak (% predicted), and carbon monoxide transfer coefficient (% predicted) showed significant prognostic relevance in both the overall cohort and the non-surgical group. In the non-surgical group, Kaplan−Meier analysis showed that patients with VO2peak below 53.4% predicted (threshold identified by receiver operating characteristic analysis) had increased mortality (p = 0.007). Interpretation: The additional measurement of cardiopulmonary exercise capacity by CPET allows a more precise prognostic evaluation in patients with CTEPH. CPET might therefore be helpful for risk-adapted treatment of CTEPH.

Identifiants

pubmed: 36286285
pii: jcdd9100333
doi: 10.3390/jcdd9100333
pmc: PMC9604581
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

BMC Pulm Med. 2021 Oct 18;21(1):324
pubmed: 34663275
Dtsch Med Wochenschr. 2013 Feb;138(6):275-80
pubmed: 23361352
Respir Med. 2021 Mar;178:106220
pubmed: 33540340
Pneumologie. 2006 Sep;60(9):576-84
pubmed: 17006795
Vasc Med. 2017 Feb;22(1):37-43
pubmed: 27707980
Pneumologie. 2018 Oct;72(10):687-731
pubmed: 30304755
Eur Respir Rev. 2017 Mar 29;26(143):
pubmed: 28356407
Chest. 2001 Mar;119(3):818-23
pubmed: 11243963
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
Pulm Circ. 2020 Apr 14;10(2):2045894020918520
pubmed: 32313643
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Respiration. 2015;90(1):63-73
pubmed: 26044754
Eur Respir J. 2004 Apr;23(4):595-600
pubmed: 15083760
Pneumologie. 2013 Jan;67(1):58-63
pubmed: 23247595
Med Sci Sports Exerc. 2008 Oct;40(10):1725-32
pubmed: 18799981
Respiration. 2014;87(5):379-87
pubmed: 24732343
Circulation. 2016 Mar 1;133(9):859-71
pubmed: 26826181
Eur Respir Rev. 2019 Dec 18;28(154):
pubmed: 31852745
BMC Pulm Med. 2012 Jun 07;12:23
pubmed: 22676304
Chest. 2007 Nov;132(5):1500-5
pubmed: 17925427
Eur Respir Rev. 2021 Jul 20;30(161):
pubmed: 34289981
Medicina (Kaunas). 2021 Apr 07;57(4):
pubmed: 33916978
Eur Respir J. 2019 May 18;53(5):
pubmed: 31023842
JACC Heart Fail. 2016 Aug;4(8):607-16
pubmed: 27289406
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Eur Respir J. 2018 Nov 8;52(5):
pubmed: 30337446
Thromb Res. 2018 Apr;164:157-162
pubmed: 28641836
Ther Adv Chronic Dis. 2021 Mar 25;12:20406223211002961
pubmed: 33854746
Thromb Res. 2013;132(6):659-65
pubmed: 24157082
Circulation. 2002 Jul 16;106(3):319-24
pubmed: 12119247
J Thorac Cardiovasc Surg. 2011 Mar;141(3):702-10
pubmed: 21335128
Int J Cardiol. 2013 Aug 20;167(4):1193-8
pubmed: 22494868
PLoS One. 2018 Jun 21;13(6):e0198198
pubmed: 29927944
Clin Med Insights Circ Respir Pulm Med. 2018 Aug 16;12:1179548418794155
pubmed: 30618489
Eur Respir J. 1993 Mar;6 Suppl 16:41-52
pubmed: 24576916
Eur Respir Rev. 2017 Mar 15;26(143):
pubmed: 28298387
Eur Respir J. 2012 Jan;39(1):119-24
pubmed: 21737552
Pneumologie. 2012 Jul;66(7):402-7
pubmed: 22623039
Blood Rev. 2014 Nov;28(6):221-6
pubmed: 25168205
Chest. 2011 Nov;140(5):1284-1291
pubmed: 21527511
Eur Respir Rev. 2021 Jan 6;30(159):
pubmed: 33408087
Clin Cardiol. 2017 Feb;40(2):95-101
pubmed: 28244596
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):704-709
pubmed: 28591785
Ann Thorac Surg. 2012 Jul;94(1):97-103; discussion 103
pubmed: 22626752
Eur Respir J. 2021 Jun 17;57(6):
pubmed: 33334946
Dtsch Med Wochenschr. 2011 Dec;136(50):2601-16; quiz 2617-20
pubmed: 22160954
Respiration. 2016;91(6):503-9
pubmed: 27327769
Int J Cardiol. 2018 Dec 1;272S:69-78
pubmed: 30195840

Auteurs

Ralf Ewert (R)

Internal Medicine B, Pneumology, University Hospital Greifswald, 17475 Greifswald, Germany.

Till Ittermann (T)

Department of Community Medicine, University Hospital Greifswald, 17489 Greifswald, Germany.

Delia Schmitt (D)

Department of Internal Medicine, Medical Missio Hospital, 97074 Würzburg, Germany.

Elena Pfeuffer-Jovic (E)

Department of Internal Medicine, Medical Missio Hospital, 97074 Würzburg, Germany.

Johannes Stucke (J)

Internal Medicine, Pneumology, University Hospital Dresden, 01307 Dresden, Germany.

Kristin Tausche (K)

Internal Medicine, Pneumology, University Hospital Dresden, 01307 Dresden, Germany.

Michael Halank (M)

Internal Medicine, Pneumology, University Hospital Dresden, 01307 Dresden, Germany.

Jörg Winkler (J)

Medical Practice, 04103 Leipzig, Germany.

Andreas Hoheisel (A)

Department of Pneumology, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Beate Stubbe (B)

Internal Medicine B, Pneumology, University Hospital Greifswald, 17475 Greifswald, Germany.

Alexander Heine (A)

Internal Medicine B, Pneumology, University Hospital Greifswald, 17475 Greifswald, Germany.

Hans-Jürgen Seyfarth (HJ)

Internal Medicine, Pneumology, University Hospital Leipzig, 04103 Leipzig, Germany.

Christian Opitz (C)

Internal Medicine, Cardiology, DRK-Hospital Berlin, 14050 Berlin, Germany.

Dirk Habedank (D)

Internal Medicine B, Pneumology, University Hospital Greifswald, 17475 Greifswald, Germany.
Internal Medicine, Cardiology, DRK-Hospital Berlin, 14050 Berlin, Germany.

Roland Wensel (R)

Internal Medicine, Cardiology, DRK-Hospital Berlin, 14050 Berlin, Germany.

Matthias Held (M)

Department of Internal Medicine, Medical Missio Hospital, 97074 Würzburg, Germany.

Classifications MeSH